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Background: The Leapfrog Group established evidence-based standards for abdominal aortic aneurysm (AAA) repair,
including targets for case volume and perioperative -blocker usage. The purpose of this study was to determine whether
meeting these benchmarks correlated with improved patient outcomes over time.
Methods: We studied California hospitals that responded to consecutive Leapfrog Group Hospital Quality and Safety
Surveys between 2000 and 2005. Survey results of compliance with Leapfrog standards were linked to patient outcomes
for AAA repair using the California state discharge database for the corresponding years. A random-effects Poisson
regression analysis was performed to measure the effect of meeting -blocker and case volume standards on hospital
mortality and average length of stay after elective open and endovascular AAA repair (EVAR) during the early
(2000-2002) and later (2003-2005) phase of Leapfrog implementation.
Results: Among 140 hospitals that performed open AAA repair, 25 (17.4%) met the Leapfrog case volume standard, 32
(22.2%) were compliant with routine perioperative -blocker use, 5 hospitals (3.5%) met both criteria, and 78 control
hospitals failed to meet either standard. After controlling for temporal differences in hospital and patient characteristics,
hospitals that implemented a policy for perioperative -blocker usage were found to have an estimated 51% reduction of
in-hospital mortality (relative risk, 0.49; 95% confidence interval, 0.24-0.99; P < .05) after open AAA repair cases
compared with control hospitals over time. There was no improvement in mortality outcomes over time, however, after
open AAA repair in hospitals meeting case volume standards. Among 111 California hospitals in which EVAR was
performed, there was an estimated 61% reduction of in-hospital mortality over time (relative risk, 0.39; 95% confidence
interval, 0.07-1.80) among hospitals meeting Leapfrog case volume standards compared with control hospitals, although
these results did not reach statistical significance. Finally, there was no reduction in length of hospital stay over time after
either EVAR or open AAA repair for hospitals meeting Leapfrog standards compared with control hospitals.
Conclusions: This population-based study supports the effectiveness of meeting Leapfrog AAA repair standards towards
improving mortality outcomes over time and suggests that their impact depends upon procedure type. Further studies are
needed to help promote the standardization of evidence-based measures that may improve vascular surgery outcomes.
( J Vasc Surg 2008;47:1155-64.)High-quality clinical research is published every year
that pertains to the diagnosis, treatment, and management
of patients with vascular disease. The practice of evidence-
based medicine (EBM) attempts to identify those interven-
tions with the best outcomes and implement them into
clinical practice.1 This translation of evidence from well-
designed observational studies and randomized controlled
trials (RCTs) into clinical practice and health care policy
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One of the largest efforts to standardize EBM in the
United States is being led by the Leapfrog Group, an
alliance of large public and private health care purchasers
representing 37 million individuals across the United
States.2 This health care consortium was founded in 2000
with the aim to exert its combined leverage towards im-
proving nationwide standards of health care quality, opti-
mizing patient outcomes, and ultimately lowering health
care costs.3-5 The Leapfrog Group’s strategy to achieve
these goals is through providing patient referral, financial
incentives, and public recognition for hospitals that practice
or implement EBM health care standards. These include
hospital use of computerized physician order entry systems,
compliance with 24-hour intensive care unit (ICU) physi-
cian staffing, evaluation using a 30-point composite Leap-
frog Safe Practices Score, and evidence-based hospital re-
ferral standards for five high-risk operations.
Elective AAA repair is one of the high-risk operations
targeted by the Leapfrog Group, with the goal to improve
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by promoting referral to hospitals compliant with specific
EBM standards for this procedure. To date, two Leapfrog
standards have been developed for hospitals in which elec-
tive AAA repair is performed and are based on collective
evidence obtained from well-designed randomized trials
and observational studies:
● The first standard was established in 2000, based on
data showing improved mortality outcomes for AAA
repair performed at high-volume hospitals.6-8 A hos-
pital case volume standard was established at 50
annual elective AAA repair procedures, including
those performed using open and endovascular AAA
repair (EVAR) techniques.
● The second standard, released in 2003, mandated that
80% of patients undergoing an AAA operation at
each hospital be prescribed a -blocker medication
during the perioperative period.5 This standard was
based on the result of several large RCTs that estab-
lished the efficacy of -blockers in patients undergoing
open AAA repair.9,10
Hospitals and surgeons are increasingly being evalu-
ated by their compliance with meeting Leapfrog standards
for elective AAA repair, although the effectiveness of these
measures over time has not been evaluated on a population
level for each type of AAA repair procedure. To address this
question, we performed a retrospective longitudinal analy-
sis of in-hospital mortality outcomes after elective EVAR
and open AAA repair among California hospitals according
to whether they met Leapfrog standards. California, with a
large number of hospitals that perform elective AAA repair,
was among the first states targeted by the Leapfrog initia-
tive. We hypothesized that hospitals in this state that met
Leapfrog criteria for AAA repair have benefited from im-
provements in postoperative mortality and length of stay
over time compared with hospitals that did not meet these
Table I. Characteristics of California hospitals responding
which elective open and endovascular abdominal aortic an
Hospital characteristics Control
No. of hospitals 78
Total admissions, mean (SD)c 12.8 (6.5)
ICU admissions, mean (SD)c 1.6 (1.7)
Staffed floor beds, mean (SD) 196.6 (93.2) 1
Staffed ICU beds, mean (SD) 21.5 (10.6)
Annual AAA volume, mean (SD) 15.4 (10.1)
Member of health system, No. (%) 78 (79)
ACGME Surgical Training, No. (%) 8 (10)
AAA, Abdominal aortic aneurysm; ACGME, Accreditation Council for Gra
aHospital strata based on meeting Leapfrog AAA standards. Control: No L
standard met; Both: Both -blocker and case volume standards met.
bOne-way analysis of variance used for comparison of means, and Chi-squa
cExpressed as mean number of total hospital admissions per year in units ofEBM standards.METHODS
Hospital and patient data. We reviewed response
data obtained from the Leapfrog Group Hospital Quality
and Safety Surveys sent to California hospitals annually
between 2001 and 2005. Surveys were sent to all acute-care
hospitals in urban areas, and data collected represented
self-reported information on hospital demographics and
annual compliance with each of the Leapfrog Group safety
standards. Of a total of 337 hospitals in California targeted
by this initiative, 140 hospitals were identified in which
AAA repair procedures were performed every year and
responded to consecutive Leapfrog Group Hospital Qual-
ity and Safety Surveys during the time period. Outcomes
among patients who underwent elective open or endovas-
cular AAA repair procedures at these hospitals were identi-
fied using the California Office of Statewide Health Plan-
ning and Development (OSHPD) database for the
corresponding years (2000-2005) and were linked by
OSHPD identification number to the Leapfrog Group
survey results.
International Classification of Diseases, 9th Revision
(ICD-9) procedure codes were used to identify open AAA
repair (38.34, 38.36, 38.44, 38.64, 39.25, 39.52) and
EVAR (39.71) procedures from the OSHPD database, and
were cross-referenced with ICD-9 diagnosis codes for non-
ruptured AAA (441, 441.0, 441.4, 441.9). The EVAR
procedure code was introduced in October 2000; there-
fore, data on this procedure are available from this point on.
The ICD-9 codes used to designate emergency or ruptured
AAA repairs were excluded from analysis. The combination
of diagnosis and procedure codes ensured that only out-
comes from elective AAA repair cases were analyzed. An
Institutional Review Board approved a protocol for this
study.
Study design. We compared hospital characteristics,
in-hospital mortality, and hospital length of stay (LOS) for
onsecutive Leapfrog surveys between 2000 and 2005 in
m repair was performeda
pen abdominal aortic aneurysm repair
locker Volume Both Pb
2 25 5
(5.0) 19.8 (6.8) 26.5 (11.1) .05
(0.8) 2.1 (1.3) 4.4 (2.8) .05
(81.8) 289.2 (109.7) 449.0 (228.1) .05
(9.9) 39.7 (21.5) 81.0 (40.8) .05
(9.1) 53.1 (31.4) 62.1 (22.7) .05
(84) 22 (88) 4 (80) 0.75
(6) 4 (16) 3 (60) .05
Medical Education; ICU, intensive care unit; SD, standard deviation.
g standard met; -blocker: -blocker standard met; Volume: Case volume
used to compare proportions between groups.
ands.to c
eurys
O
-B
3
12.4
1.5
87.8
21.1
15.7
27
2
duate
eapfro
re testtwo consecutive time periods:
JOURNAL OF VASCULAR SURGERY
Volume 47, Number 6 Brooke et al 11571. the initial 3-year period during which the Leapfrog Group
established procedure volume standards for AAA repair
and released the first version of the Leapfrog Group Hos-
pital Quality and Safety Survey (2000 to 2002); and
2. the 3-year period after both standards for AAA case
volume and -blocker standards were established by
Leapfrog (2003 to 2005).
Given that in-hospital outcomes after elective AAA
repair are known to differ by whether the procedure is
performed using EVAR or open techniques, all analyses
were performed after stratifying by the type of proce-
dure.11,12 Hospitals were stratified into one control group
and three comparison groups according to their fulfillment
of Leapfrog AAA repair volume and perioperative
-blocker usage standards:
1. hospitals that did not meet either Leapfrog AAA repair
standard (controls);
2. hospitals that met the AAA case volume standard alone
(average of 50 or more annual AAA repair cases) during
both time periods;
3. hospitals that met the perioperative -blocker standard
alone after 2003; and
4. hospitals that met both the -blocker and case volume
standard.
Hospital level covariates that were analyzed included
the number of total annual admissions, number of floor
admissions, number of ICU admissions, number of staffed
floor beds, number of licensed floor beds, number of staffed
ICU beds, number of licensed ICU beds, hospital mem-
bership status in health organization, presence of an Ac-
creditation Council for Graduate Medical Education
(ACGME) accredited general surgery or vascular surgery
residency training program, the total number of elective
AAA repairs reported by survey, and the proportion of
EVAR to open AAA repair cases performed within individ-
ual hospitals over time. Patient level variables that were
analyzed included age, sex, race, ethnicity, insurance status,
Table I. Continued.
Endovascula
Control -Blocker
58 25
13.2 (5.6) 13.4 (4.8)
1.8 (2.7) 1.5 (0.7)
210.8 (77.0) 210.8 (93.8) 3
22.6 (9.7) 22.7 (10.5)
17.2 (10.7) 19.3 (9.6)
48 (83) 20 (80)
6 (10) 1 (4)and Charlson Comorbidity Index score. The main out-come measures were in-hospital mortality and median hos-
pital LOS after elective AAA repair.
Statistical analysis. We compared hospital character-
istics, in-hospital mortality, and LOS before and after Leap-
frog AAA standards between each of the defined groups
using 2 tests for categoric variables and analysis of variance
(ANOVA) or Student paired t tests for continuous variables
that were normally distributed. The Wilcoxon signed rank
test was used to compare nonparametric data between time
periods. A Poisson regression model, with a random inter-
cept for each hospital, was used to estimate the effect of
meeting Leapfrog -blocker and case volume standards on
in-hospital mortality with and without adjusting for hospi-
tal and patient-level confounders.
To estimate the independent effect of these two EBM
standards, data were pooled from hospitals that met both
Leapfrog standards to create two hospital subgroups that
met either -blocker or case volume standards, respectively.
The effect of Leapfrog standards on in-hospital mortality
after AAA repair was calculated as the mortality rate ratio
for hospitals that met each Leapfrog standard category (2
subgroups) vs hospitals that did not meet any Leapfrog
standards (control group) for each time period.
A ratio of mortality rate ratios was calculated separately for
the comparison of each Leapfrog subgroup with the control
group over time. The effect of Leapfrog standards on hospital
LOS was analyzed using a linear regression model and fit using
a random intercept for each hospital and a log-normal distri-
bution. Values of P less than   0.05 (two-sided) were
considered to be significant for all statistical tests and models.
Stata 9.0 statistical software (StataCorp, College Station,
Texas) was used for all analyses.
RESULTS
Hospital and patient characteristics. Baseline char-
acteristics of the California hospitals analyzed in this study
are reported in Table I, with the four groups defined by
hospital compliance with Leapfrog standards after stratify-
rysm repair
ume Both Pb
3 5
(6.2) 26.5 (11.1) .05
(1.2) 4.4 (2.8) .05
(104.1) 449.0 (228.1) .05
(19.8) 81.0 (40.8) .05
(36.4) 65.7 (25.7) .05
(87) 4 (80) 0.93
(17) 3 (60) .05r aneu
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(17.4%) met only the Leapfrog case volume standard dur-
ing either time period, 32 (22.2%) reported compliance
with only the perioperative -blocker usage standard be-
ginning in 2003, 5 (3.5%) reported meeting both of these
Leapfrog AAA repair standards during the defined time
period, and 78 (56%) reported not meeting either Leapfrog
AAA standard during the entire study period and were
defined as controls. In addition, 111 California hospitals
responded to consecutive Leapfrog surveys and performed
EVAR cases during the study time period, including 23
(21%) that met case volume criteria alone, 25 (23%) that
implemented the -blocker standard alone, 5 (5%) that met
both AAA standards, and 58 (52%) that did not meet either
standard.
For hospitals in which both EVAR and open AAA
repair cases were performed, those that met case volume or
both Leapfrog standards had a significantly higher mean
annual number of total and ICU admissions (P .05) and
higher number of floor and ICU beds (P .05) compared
with control hospitals that met none of the Leapfrog stan-
dard or hospitals that met only the -blocker standard.
These larger hospitals were also more likely to contain an
ACGME-accredited general surgery or vascular surgery
training program, although no difference existed between
hospitals’ Leapfrog status and their association with an
Table II. Characteristics of patient population undergoing
repair in California hospitals stratified by compliance with
Demographics Control -B
Patient total 3407 14
Men, No. (%) 2,702 (21) 1,169
Age, mean (SD) y 73.5 (7.8) 73.4
Age, No. (%) y
34 0 (0) 0
35-64 573 (17) 224
65 2,833 (83) 1,272
Race, No. (%)
White 2,942 (86) 1,318
Black 108 (3) 38
Latino 112 (3) 66
Asian 152 (4) 58
Other 92 (3) 18
Insurance, No. (%)
Medicare 2,550 (75) 1,175
Medicaid 78 (2) 21
Private 709 (21) 276
Self-pay, other 31 (1) 13
Charlson Index, No. (%)
1 1,369 (40) 582
2 1,141 (33) 506
3 472 (14) 206
4 425 (12) 203
SD, Standard deviation.
aHospital strata based on meeting Leapfrog abdominal aortic aneurysm sta
Volume: Case volume standard met; Both: Both -blocker and case volum
bOne-way analysis of variance used for comparison of means, and 2 test usorganized health care system (Table I). Finally, althoughhospitals meeting case volume or both Leapfrog standards
averaged a higher number of elective endovascular and
open AAA cases per year, there was no significant difference
in annual case volume between hospitals complying with
the -blocker standard and those hospitals failing to meet
any Leapfrog standard.
The demographic makeup of patients’ that underwent
open and endovascular AAA repair in California hospitals
responding to Leapfrog Group Hospital Quality and Safety
Surveys between 2000 and 2005 is reported in Table II.
During the study period, 8570 patients underwent open
AAA repair, including 1497 (17%) at hospitals that imple-
mented routine perioperative -blocker use after 2003,
2,996 (35%) at hospitals that met the case volume standard,
670 (8%) at hospitals that met both standards, and 3407
(40%) at control hospitals. During the same time period,
EVAR was performed on 4323 patients, including 704 (16%)
at hospitals that met the perioperative -blockade standard,
1783 (41%) at hospitals at met the minimum AAA volume
standard, 499 (12%) at hospitals that met both Leapfrog
standards, and 1337 elective cases (31%) at hospitals that failed
to meet any Leapfrog standard.
For patients undergoing both types of AAA repair
procedures, there was no significant difference in the mean
age, sex, insurance status, or Charlson Comorbidity Index
score among the patient populations treated in hospitals
ctive open and endovascular abdominal aortic aneurysm
frog standardsa
abdominal aortic aneurysm repair
Volume Both Pb
2996 670
) 2,366 (21) 533 (20) .84
) 73.1 (7.6) 73.0 (8.5)
.18
0 (0) 0 (0)
) 520 (17) 109 (16)
) 2,476 (83) 559 (83)
.05
) 2,766 (92) 569 (85)
27 (1) 35 (5)
65 (2) 18 (3)
91 (3) 44 (7)
47 (2) 4 (1)
.15
) 2,264 (76) 516 (77)
60 (2) 24 (4)
) 635 (21) 125 (19)
10 (0) 2 (0)
.25
) 1,225 (41) 294 (43)
) 1,009 (34) 211 (32)
) 428 (14) 96 (14)
) 334 (11) 69 (11)
s. Control: No Leapfrog standard met; -blocker: -blocker standard met;
ards met.
compare proportions between groups.ele
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formed a higher proportion of both EVAR and open cases
on African American and Asian patients compared with
other hospitals in the analysis.
In-hospital mortality. The average in-hospital mor-
tality rates after elective open and endovascular AAA repair
among California hospitals in different Leapfrog strata dur-
ing both time periods are summarized in Table III. Among
open AAA repair cases, a trend towards increasing mortality
rates over time was observed among control hospitals as
well as hospitals that met case volume and both Leapfrog
standards. In comparison, in-hospital mortality after open
AAA repair trended lower after low-volume hospitals im-
plemented the -blocker standard by the later time period
(4.93% vs 3.25%; P  .12, Table III). When both low and
high-volume hospitals that implemented a hospital policy
for routine perioperative -blocker use after 2003 were
analyzed together, this mortality benefit persisted (Fig 1).
A random-effects regression model was used to control
for changes in patient and hospital variables over time, and
an estimated 51% reduction in mortality (relative risk [RR],
0.49; 95% confidence interval [CI], 0.24-0.99; P  .05)
after open AAA cases was found among all California
hospitals that implemented a policy for routine -blocker
use compared with control hospitals. In comparison, ad-
justed regression models found no significant difference in
Table II. Continued.
Endovascula
Control -Blocker
1337 704
1,123 (84) 603 (86)
76.2 (6.9) 75.6 (7.0)
1 (0)
140 (10) 70 (10)
1,197 (90) 634 (90)
1,187 (89) 619 (88)
20 (2) 20 (3)
32 (2) 31 (4)
69 (5) 22 (3)
29 (2) 12 (2)
1,094 (82) 586 (83)
22 (2) 11 (2)
216 (16) 101 (14)
5 (0) 6 (1)
573 (43) 320 (45)
464 (35) 237 (34)
175 (13) 89 (13)
125 (9) 58 (8)open AAA in-hospital mortality during the consecutivetime periods among all hospitals that met Leapfrog case
volume standards (Table IV).
In-hospital mortality rates after EVAR cases were not
observed to significantly change during the consecutive
time periods among control hospitals and low-volume hos-
pitals that met the -blocker standard (Table III). In com-
parison, a trend towards lower mortality rates between time
periods after EVAR cases was found among hospitals that
met only case volume (1.16% vs 0.63%; P  .25) and both
Leapfrog standards (1.16% vs 0.31%; P  .08).
When all California hospitals in the study that met case
volume criteria were analyzed together, compliance with
this Leapfrog standard was found to reduce in-hospital
mortality after EVAR during the consecutive time periods
to a larger extent than control hospitals or those that met
-blocker standards (Fig 1). The adjusted in-hospital mor-
tality rate after EVAR cases was estimated to have been
reduced by 61% over time (RR, 0.39; 95% CI, 0.07-1.80;
P  .26) among hospitals that met case volume standards
compared with control hospitals, although this result did
not reach statistical significance (Table V).
Hospital length of stay. The mean  standard devi-
ation hospital LOS among patients undergoing elective
open and endovascular AAA repair at California hospitals
stratified by Leapfrog standard compliance for the consec-
utive time periods is reported in Table III. No significant
rysm repair
ume Both Pb
83 499
(86) 436 (87) .49
(7.6) 76.4 (8.1)
.70
(0) 0 (0)
(11) 58 (12)
(89) 441 (88)
.05
(89) 398 (80)
(2) 41 (8)
(3) 10 (2)
(4) 44 (9)
(2) 6 (1)
.28
(82) 414 (83)
(2) 8 (2)
(14) 74 (15)
(2) 3 (0)
.17
(46) 199 (40)
(33) 181 (36)
(13) 67 (13)
(7) 52 (10)r aneu
Vol
17
1,524
75.3
1
202
1,581
1,596
30
51
74
32
1,459
28
254
42
827
586
239
131change in LOS after open AAA repair was found among
iods u
rank
JOURNAL OF VASCULAR SURGERY
June 20081160 Brooke et alcontrol hospitals and those meeting -blocker and case
volume standards over time (Fig 2). In comparison, a trend
towards lower hospital LOS after EVAR cases over time was
Fig 1. Comparison of mean death rates for elective open abdom-
inal aortic aneurysm (AAA) and endovascular AAA repair (EVAR)
in California hospitals meeting Leapfrog standards for the 3-year
periods during early (2000-2002) and later (2003-2005) phases of
initiative. A significant decrease in mean death rates after open
AAA repair was observed in the later time period for hospitals that
implemented a policy for routine perioperative -blocker use. In
comparison, mortality rates after open AAA repair for control
hospitals and those meeting Leapfrog case volume standards
trended higher over consecutive time periods. Average in-hospital
death rates after EVAR cases trended lower for all hospital groups
over time, although the greatest reduction in mortality was ob-
served among hospitals that met AAA case volume. Error bars
represent the standard error of the mean.
Table III. Clinical outcomes after endovascular and open
responding to Leapfrog surveys during early (2000-2002)
Leapfrog standard(s)
Elective cases, No. In-ho
2000-02 2003-05 2000-20
Control (no standard)
Open AAA (n  78) 1923 1484 74 (3.85
EVAR (n  58) 397 940 8 (2.02
-Blocker standard
Open AAA (n  32) 913 584 45 (4.93
EVAR (n  25) 261 443 3 (1.15
Case volume standard
Open AAA (n  25) 1743 1253 69 (3.96
EVAR (n  23) 517 1266 6 (1.16
Both standards
Open AAA (n  5) 406 264 11 (2.71
EVAR (n  5) 172 327 2 (1.16
AAA, Abdominal aortic aneurysm; EVAR, endovascular aneurysm repair; S
aHospitals stratified into four groups based on compliance with individual L
bP values calculated for overall in-hospital mortality rates between time per
cP values calculated for mean length of hospital stay using Wilcoxon signedobserved among both control hospitals and those meetingLeapfrog standards (Table III and Fig 2). When hospitals
meeting Leapfrog -blocker and case volume standards
were compared with control hospitals in adjusted log-
normal regression models, however, no significant differ-
ence was found in LOS after EVAR cases during the
consecutive time periods.
DISCUSSION
Abdominal aortic aneurysm repair is among five high-risk
operations targeted by the Leapfrog Group for evidence-
based hospital referral standards. The specific criteria for these
standards is based on evidence that elective AAA repair per-
formed at hospitals meeting minimum procedure volume
and complying with perioperative -blockade should ben-
efit from a significant reduction in postoperative morbidity
and mortality.5,7-10 The generalizability of applying these
EBM standards toward improving AAA postoperative out-
comes remains controversial, however, given that their
effectiveness has not been demonstrated using data from
participating hospitals. To our knowledge, this is the first
population-based study to directly measure the temporal
impact of meeting Leapfrog standards for AAA repair on
clinical outcomes.
Our data indicate that patients who had open AAA
repair in California hospitals that implemented the Leap-
frog standard for perioperative -blockade experienced an
estimated 50% reduction in postoperative mortality over
time compared with patients who had operations in control
hospitals that did not meet any quality standards. Patients
who underwent EVAR in California hospitals that met
Leapfrog case volume standards also appeared to benefit
from a reduction in mortality over time, although this
finding did not reach statistical significance. These results
suggest that hospital compliance with Leapfrog standards
for elective AAA repair is an effective means to help improve
minal aortic aneurysm repair in California hospitals
later (2003-2005) phase of implementationa
l mortality, No. (%)
Length of hospital stay, mean (SD)
days
2003-2005 Pb 2000-2002 2003-2005 Pc
75 (5.05) .09 7.09 (1.7) 7.48 (3.0) .33
18 (1.91) .99 4.10 (2.9) 3.44 (2.4) .21
19 (3.25) .12 7.23 (2.3) 7.19 (1.6) .94
7 (1.58) .75 5.70 (5.5) 4.21 (5.7) .39
55 (4.39) .56 6.92 (1.2) 6.94 (1.0) .95
8 (0.63) .25 3.02 (2.2) 2.30 (1.4) .19
11 (4.17) .30 6.30 (1.9) 6.20 (1.5) .93
1 (0.31) .08 3.50 (1.3) 2.30 (0.4) .09
ndard deviation.
og standards for AAA repair.
sing 2 and Fisher exact test.
test.abdo
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)
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eapfrin-hospital mortality outcomes over time and support fur-
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pitals that comply with other EBM standards.
There has been considerable controversy regarding re-
ferral patterns and the development of centers of excellence
for high-risk operations such as AAA repair.13-17 Much of
the debate has centered on deciding what specific measures
should be used to assess hospital and surgical quality.
Hospital procedure volume emerged as an important met-
ric early in this process and was used as the sole standard for
AAA repair when the first Leapfrog surveys were released in
2001. The use of a volume threshold alone to define
hospital quality has been challenged, however,15,16,18 in-
cluding an inability to arrive at a consensus for appropriate
volume cutoffs, the exclusion of low-volume hospitals that
have excellent outcomes, and the argument that hospital
volume serves as merely a proxy for many other process
measures that ultimately determine clinical outcomes.
Furthermore, although AAA volume standards were
originally developed as a metric for open AAA cases, our
Table IV. Mortality rate ratio estimates for open abdomin
Leapfrog -blocker and case volume standards compared w
2002) and later (2003-2005) phase of implementationa
Leapfrog standard
Rate ratio Leapfrog st
2000-2002 (95% CI)
Control, no standard (n  78) 1.00 (Ref)
-blockade standard (n  37)
Unadjusted 1.12 (0.75-1.67)
Adjustedb 1.56 (0.97-2.49)
Case volume standard (n  30)
Unadjusted 1.01 (0.71-1.44)
Adjustedc 1.32 (0.84-2.07)
aRandom effects Poisson regression models used with intercept for each ho
bPoisson models adjusted for race, insurance type, sex, age, Charlson comor
hospital abdominal aortic aneurysm volume.
cPoisson models adjusted for race, insurance type, sex, age, Charlson com
compliance with -blocker standard.
Table V. Mortality rate ratio estimates for endovascular ab
met Leapfrog -blocker and case volume standards compa
(2000-2002) and later (2003-2005) phase of implementat
Leapfrog standard
Rate ratio Leapfrog st
2000-2002 (95% CI)
Control, no standard (n  58) 1.00 (Ref)
-blockade standard (n  30)
Unadjusted 0.57 (0.19-1.75)
Adjustedb 0.78 (0.14-4.36)
Case volume standard (n  28)
Unadjusted 0.61 (0.20-1.88)
Adjustedc 1.25 (0.28-4.72)
aRandom effects Poisson regression models used with intercept for each ho
bPoisson models adjusted for race, insurance type, sex, age, Charlson comor
hospital AAA case volume.
cPoisson models adjusted for race, insurance type, sex, age, Charlson comor
whether hospital reported compliance with -blocker standard.data suggest that this measure has the greatest impact onimproving EVAR outcomes over time. Our study was
underpowered to achieve statistical significance; neverthe-
less, these findings are consistent with the results of a recent
large nationwide cohort study that showed that outcomes
for EVAR steadily improved from 2000 to 2003 as volume
increased, whereas open AAA repair outcomes remained
fairly constant.19 Given that hospitals in our study that met
Leapfrog case volume criteria performed most of the elec-
tive AAA repairs after 2003 using EVAR techniques (Table
III), perhaps it should not come as a surprise that this
procedure benefited the most within hospitals meeting this
standard.
Despite the benefits of case volume on AAA outcomes,
most hospitals across the country do not have the referral
pattern or the infrastructure to meet this standard.15,16 The
addition of hospital compliance with perioperative-blockade
in 2003 as a second criteria for elective AAA repair helped
address this limitation by allowing hospitals of all sizes to
implement a process-based measure.5 As our data show,
rtic aneurysm repair at California hospitals that met
hospitals that met neither standard during early (2000-
rd vs control
Ratio of rate ratios (95% CI) P3-2005 (95% CI)
00 (Ref) 1.00 (Ref)
70 (0.45-1.08) 0.63 (0.36-1.09) .097
69 (0.39-1.22) 0.49 (0.24-0.99) .048
86 (0.62-1.20) 0.86 (0.54-1.37) .53
02 (0.66-1.59) 0.80 (0.44-1.45) .47
to estimate difference in mortality rate between time periods.
index score, total hospital and intensive care unit admissions, case-mix, and
ty index score, total hospital and ICU admissions, case-mix, and hospital
inal aortic aneurysm repair at California hospitals that
ith hospitals that met neither standard during early
rd vs control
Ratio of rate ratios, (95% CI) P3-2005 (95% CI)
00 (Ref) 1.00 (Ref)
54 (0.24-1.25) 0.95 (0.23-3.81) .94
90 (0.34-6.73) 1.14 (0.168.33) .90
29 (0.13-0.66) 0.54 (0.151.98) .35
62 (0.22-1.70) 0.39 (0.07-1.80) .26
to estimate difference in mortality rate between time periods.
index score, total hospital and intensive care unit admissions, case-mix, and
index score, total hospital and intensive care unit admissions, case-mix, andal ao
ith
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biditythis standard was put into practice primarily by lower-
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AAA cases with traditional open repair (Tables I and III).
An interesting finding of this study is that the dramatic
reduction of in-hospital mortality for the time period after
implementation of the -blocker standard was achieved
through reduction of in-hospital mortality after open AAA
cases, but not EVAR procedures (Table III). These data
suggest that process measures such as perioperative
-blocker usage are most critical to implement during
procedures such as open AAA repair that require longer
hospital LOS. Together, both Leapfrog standards provide
quality benchmarks for AAA repair that large and small
hospitals in which endovascular and open AAA repair is
performed should aim to achieve.
The study has several important limitations. First, the
validity of this study relies on controlling for factors that
may have changed differentially over time between control
hospitals and those meeting Leapfrog standards. These
include temporal changes in risk stratification, device im-
provements, and technical issues related to the operative
repair. Our model adjusts for some patient factors that
influence operative risk, but the use of an administrative
database precludes the ability to control for all of these
other important variables that may have changed differen-
tially over time.
Second, the assignment of Leapfrog compliance for
Fig 2. Comparison of mean hospital length of stay for abdominal
aortic aneurysms (AAA) repaired electively by open and endovas-
cular (EVAR) techniques in California hospitals meeting Leapfrog
standards for early (2000-2002) and later (2003-2005) phases of
the initiative. No decrease in hospital length of stay over time after
open AAA repair was observed among control hospitals and those
meeting -blocker and case volume standards. In comparison,
hospital length of stay after EVAR cases decreased over consecutive
time periods to a similar extent among both control hospitals and
those meeting Leapfrog standards. Error bars represent the stan-
dard error of the mean.-blocker and case volume by individual hospitals wasmade using self-reported survey data, and clinical outcomes
were assessed retrospectively. Only urban California hospi-
tals that returned surveys during consecutive periods were
included in the analysis, but it is possible that hospitals not
responding to Leapfrog surveys might have worse clinical
outcomes and thus increase the overall treatment benefit
for hospitals meeting Leapfrog standards for AAA repair.
Third, this analysis is limited to 140 hospitals in a single
state, although the diverse demographic makeup of Cali-
fornia provides a reasonable population from which to
extrapolate the effect of Leapfrog AAA repair standards
over time to the rest of the nation.
Fourth, the survey data used for this analysis only
allowed us to document whether there was a hospital-level
policy for perioperative -blocker use, and we did not have
patient level data showing medication usage or hemody-
namic variables to confirm this. Nevertheless, our analysis
was designed to demonstrate the effectiveness of imple-
menting a hospital policy for -blocker use on a population
level, not to re-evaluate their efficacy at the patient level.
Finally, the analysis of in-hospital dependent variables
for this study does not tell us whether long-term outcomes
were different among hospitals that met different Leapfrog
criteria. Indeed, it appears that a longer follow-up period or
a larger population sample size will be necessary to show a
statistically significant effect of meeting Leapfrog case vol-
ume standards on mortality outcomes after EVAR cases.
CONCLUSIONS
This population-level analysis among California hospi-
tals provides evidence supporting patient referral to medical
centers meeting Leapfrog case volume and -blocker stan-
dards for EVAR and open AAA repair, respectively. It will
be important to confirm these findings among larger na-
tional data sets. Continuing to apply EBM standards to-
ward improving patient care and clinical outcomes for
elective AAA repair, as well as other high-risk vascular
procedures, will ensure that patients receive the highest
standard of care.
We are grateful to J. Dennis Bush (Thomson Health-
care) and Sarah Collins (LeapFrog Group) for their help
obtaining LeapFrog Group survey data, and Aidan McDer-
mott for assistance with executing the statistical analysis of
this study.
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Dr Anil Hingorani (Brooklyn, NY). I want to congratulate
you on analyzing such a large data set because I think it is the only
way we are going to be able to get at some of these questions.
However, when you are dealing with these large data sets, one
common problem is that you really can’t get at some of the details.
First, I don’t know how you ended up with the data set from
California, being from Johns Hopkins, but I congratulate you on
acquiring it and analyzing it. One thing I am really concerned
about when I read over the abstract is that there were only five
hospitals in the last group that met both standards. Whenever you
have such a large data set and only five hospitals in one group and
you’re trying to derive data from there, I think some of your
conclusions may not be as solid.
This is still a retrospective database, and the prospective data
that has looked at aneurysms has already shown that -blockers are
quite clearly beneficial in perioperative outcome in terms of mor-
tality, and probably long-term survival of these patients, irrespec-
tive of whether they have coronary artery disease. What I am
actually more interested in seeing is whether or not some of the
other retrospective data that have suggested statins may be useful
in these patients, which was not addressed in these groups but your
group has looked at before.
I want to congratulate you on analyzing such a large data set.
I think it was a valiant attempt. But the fact that there were only five
hospitals in the last group that met both standards raises some
questions in the fact that there are only 25 hospitals in one group,
and 32 hospitals in the other group, still leads me to still question
some of the conclusions.
Dr Benjamin Brooke. This analysis was focused on California
hospitals alone for a number of different reasons. For one, Leap-
frog was rolled out in phases, and California was one of the few
states targeted in the first rollout period beginning in 2000 to
2001. Second, this state contained the largest number of hospitals
targeted by the initiative overall, so it offered us the most robustpopulation from which to generalize our results to the broader
community. The fact that only five hospitals in this state met both
Leapfrog criteria should not come as a surprise, given the results of
previous studies showing that only a small number of hospitals in
California are able to meet Leapfrog’s volume criteria. While
outcomes at these hospitals were significantly improved compared
with control hospitals, you are correct that we need to be careful
about extrapolating too much from limited data. To address these
limitations, we plan to do future analyses that measure the clinical
impact of Leapfrog standards for AAA repair using a large nation-
wide data set among Medicare beneficiaries.
You raise another excellent point about the fact that we are
evaluating the effect of implementing known evidence-based stan-
dards such as -blocker use. But one of the main reasons for doing
this analysis is to address the question: If the evidence is based on
well-designed randomized trials and is already out there, why
aren’t more hospitals standardizing -blocker use during elective
AAA repair? Indeed, our analysis was not designed to evaluate the
efficacy of Leapfrog standards on elective AAA repair; its primary
intent was to look at their effectiveness on a population basis.
Finally, you are absolutely correct about the evidence for statin
use, and I agree that Leapfrog should consider this process measure
as another evidence-based standard for hospitals performing elec-
tive AAA repair.
Dr John Blebea (Philadelphia, Pa). I am a bit concerned
about your conclusions. It appears too simplistic to ascribe out-
comes of AAA repair to only these two variables. I would propose
that the use of -blockers and volume may be an associated variable
but possibly not be a causal one. One could hypothesize that larger
hospitals would be more interested in complying with Leapfrog
standards compared with smaller hospitals. Additionally, it is pos-
sible that hospitals with less prevalent -blocker usage had a larger
percentage of patients with COPD who would therefore not be
given -blockers but would be at higher risk for surgical morbidity
and mortality. Therefore, these two variables alone may not be
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with improved clinical results. Since you have demonstrated that
EVAR vs open surgery has a very large positive impact on mortal-
ity, have you done a multivariate analysis to better determine
possible causal relationships?
Secondly, is there a significant difference in outcome predict-
ability using -blockade, volume, or a combination of both factors?
It appeared that the results were similar or was one single variable
more important?
Dr Brooke. You made an excellent point about the different
types of patients that may be treated in hospitals meeting Leapfrog
standards for AAA repair versus hospitals that don’t meet these
criteria. Indeed, we considered using a multilevel or hierarchal
model for this analysis, which would allow for adjustment of both
patient-level and hospital-level confounders and help risk stratify
the types of patients that are being treated at different hospital
groups. However, a multilevel analysis becomes more complicated
to interpret and would require more observations among hospitals
meeting both Leapfrog standards. We focused on hospital-level
outcomes because we were looking at effectiveness of Leapfrog
standards for AAA repair on a population basis, and for process
measures like -blocker usage, you don’t have patient-level data;
only self-reported hospital data stating whether they comply with
that standard or not.
As far as doing a multivariate analysis, we in fact adjusted for
hospital level variables using Poisson regression models for each of
the Leapfrog hospital groups. Because we stratified outcomes by
the type of procedure, an EVAR variable wasn’t adjusted for in thisregression model. However, we adjusted for all the other hospital-
level variables, such as number of floor or ICU admissions, number
of beds, teaching status, et cetera, and consistently found in-
hospital mortality to be lower for hospitals meeting Leapfrog
standards.
In regards to your last comment about measuring the inde-
pendent effect of -blocker vs volume in a multivariable analysis,
while the reported outcomes were obtained by comparing hospi-
tals meeting individual Leapfrog standards to control hospitals in
separate models, similar results were obtained when all Leapfrog
standard variables were included in the same model. We chose to
develop separate multivariate models for each Leapfrog standard
due to concerns about the collinearity of similar variables in a single
model.
Dr Ali F. AbuRahma (Charleston, WV). Did you look into
the impact of endovascular procedures in these hospitals on the
length of stay for the open repair? I just noticed in our institution
that the people who do an open surgery start to release their
patients even much earlier so they will have a favorable outcome
against the endovascular repair. Did you notice the same in your
experience, sir?
Dr Brooke. While there was a very slight trend in reduction of
length of stay for the hospitals that met both Leapfrog standards,
you really couldn’t say there was any difference given the variance.
So no, we didn’t see any temporal changes for length of stay among
open AAA cases. It was only for endovascular AAA repair cases in
our population.
